Corruption at it's worse. I don't think I could hate this woman more....

On Tuesday, September 20, 2016 at 8:19:01 PM UTC-6, Perplexed wrote:
>
>
> And even the New York Times admitted it. I came across this in researching 
> the recent allegations that the Clinton Foundation used an Indian drug 
> manufacturer that is prohibited from selling drugs in the US due to its 
> known horrific lack of quality. This was from 2007:
>
> Clinton Foundation Announces a Bargain* on Generic AIDS Drugs 
>
> By CELIA W. DUGGER <http://www.nytimes.com/by/celia-w-dugger>MAY 9, 2007 
>
> Former President Bill Clinton announced yesterday that his foundation had 
> negotiated deep price reductions for generic versions of costly, 
> second-line AIDS 
> <http://topics.nytimes.com/top/news/health/diseasesconditionsandhealthtopics/aids/index.html?inline=nyt-classifier>
>  
> drugs needed when the original medicines fail, as well as for less toxic, 
> easier-to-use first-line medicines combined in a pill that can be taken 
> once a day.
>
>
> Standing next to Thailand 
> <http://topics.nytimes.com/top/news/international/countriesandterritories/thailand/index.html?inline=nyt-geo>’s
>  
> health minister, Mr. Clinton also forcefully endorsed recent decisions by 
> Thailand and Brazil 
> <http://topics.nytimes.com/top/news/international/countriesandterritories/brazil/index.html?inline=nyt-geo>
>  
> to break patents held by American pharmaceutical companies that are 
> charging prices Mr. Clinton described as exorbitant, but that drug company 
> officials said were reasonable.
>
> “No company will live or die because of high price premiums for AIDS drugs 
> in middle-income countries, but patients may,” he said.
>
>
> The new prices would halve the cost of the drugs for better-off developing 
> countries in Latin America and Asia and cut prices by 25 percent in poor 
> countries, which were already paying lower prices, the foundation said. The 
> second-line medicines will be bought with more than $100 million raised by 
> a group of countries led by France. The improved first-line therapies will 
> largely be financed by the Global Fund to Fight AIDS, Tuberculosis and 
> Malaria and other donors.
>
>
> Second-line drugs have typically cost about 10 times as much as first-line 
> therapies. Costs have ballooned in Brazil and Thailand, which began 
> programs to provide universal access to AIDS treatment years before African 
> countries did, as patients have developed resistance to generic first-line 
> treatments and have moved to brand-name second-line drugs.
>
>
> The Clinton Foundation’s willingness to buy the generic drugs from the 
> Indian manufacturers Cipla and Matrix will give developing countries 
> leverage in bargaining with American companies for lower prices on branded 
> antiretroviral drugs and may embolden some to follow Brazil and Thailand in 
> overriding patents, AIDS activists said.
>
>
> But developing countries still have reason to worry about retaliation from 
> drug companies and trade sanctions by the United States. This year, Abbott 
> Laboratories, based in Illinois, withdrew new drugs, including those for 
> high blood pressure 
> <http://topics.nytimes.com/top/news/health/diseasesconditionsandhealthtopics/bloodpressure/index.html?inline=nyt-classifier>
>  
> and AIDS, that it had planned to introduce in Thailand until the override 
> on Abbott’s patent on the second-line drug, Kaletra.
>
>
> United States trade officials last week put Thailand on a watch list for 
> countries inadequately safeguarding the intellectual property rights of 
> American companies, noting the overriding of drug patents.
>
>
> Tido von Shoen-Angerer, who leads the campaign by Doctors Without Borders 
> for access to medicines, said he was unsure whether the recent developments 
> would encourage developing countries to exercise their rights under 
> international trade rules more freely to make or import generic drugs.
>
> “There’s a strong chilling effect from the U.S. action,” he said.
>
>
> Drug company officials yesterday strongly defended their policies of 
> charging better-off developing countries more for AIDS drugs than they did 
> for poor countries, as well as the role of patents, which give inventor 
> companies a monopoly on the sale of a drug, in stimulating the development 
> of new drugs.
>
>
> Jennifer Smoter, a spokeswoman for Abbott, said patents were needed “to 
> ensure innovation in the future” but declined to respond to Mr. Clinton’s 
> comment that “Abbott has been almost alone in its hard-line position here 
> over what I consider to be a life and death matter.”
>
>
> Abbott had been charging $2,200 annually per patient for Kaletra in 
> middle-income developing countries, which include India, China, Brazil and 
> Ukraine. Last month, it dropped the price to $1,000. The foundation’s new 
> price for the generic is $695.
>
>
> Jeffrey L. Sturchio, a vice president at Merck 
> <http://topics.nytimes.com/top/news/business/companies/merck_and_company/index.html?inline=nyt-org>
>  
> in New Jersey, says his company strives to balance providing the broadest 
> possible access to AIDS drugs while maintaining financial incentives to 
> attract companies to conduct research and development on new drugs.
>
>
> Brazil and Thailand have overridden Merck’s patent on the AIDS drug 
> efavirenz, an ingredient of the new, improved first-line AIDS therapies. 
> Merck had been charging Brazil $577 annually per patient, a price it agreed 
> to drop to $400 a year after Brazil said it was considering overriding the 
> patent. The Clinton Foundation’s new price for the generic drug is $164.
>
>
> http://www.nytimes.com/2007/05/09/world/09aidsdrugs.html?_r=0
>
>
> *Bill Clinton, a former president of the United States and then husband of 
> a US Senator from NY, encouraged two foreign governments to break patents 
> held by two US companies - because he decided their prices were too high. 
> To hell with the precedent set, right?
>
>
> If elected, Hillary wouldn't wait until she's out of office to be doing 
> this shit. It's "America last" with these two. :(
>
>
>
>
>
>
>

-- 
-- 
Thanks for being part of "PoliticalForum" at Google Groups.
For options & help see http://groups.google.com/group/PoliticalForum

* Visit our other community at http://www.PoliticalForum.com/  
* It's active and moderated. Register and vote in our polls. 
* Read the latest breaking news, and more.

--- 
You received this message because you are subscribed to the Google Groups 
"PoliticalForum" group.
To unsubscribe from this group and stop receiving emails from it, send an email 
to politicalforum+unsubscr...@googlegroups.com.
For more options, visit https://groups.google.com/d/optout.

Reply via email to